MEDecision, Inc. (Nasdaq: MEDE), a leading provider of collaborative health care management solutions, today announced that it has named Andrew P. Schuyler, M.D. Executive Vice President and Chief Medical Officer (CMO). Dr. Schuyler joins MEDecision from Horizon Blue Cross Blue Shield (BCBS) of New Jersey, where he was executive medical director. As CMO, Dr. Schuyler will be responsible for overseeing MEDecision�s clinical leadership and excellence. He will work with other members of the company�s clinical staff to extend MEDecision�s strong position in collaborative health care management as it continues its shift from product development to execution and customer satisfaction. �Dr. Schuyler�s vast experience and expertise make him an ideal fit for this position and will enable him to continue growing MEDecision�s clinical initiatives,� said David St.Clair, Founder and CEO of MEDecision. �We�re very pleased to have someone with his credentials in this important role as we increase our emphasis on clinical excellence and meeting the health care management needs of our customers.� �This is a very exciting time for MEDecision,� said Dr. Schuyler. �With its new products, Alineo and Nexalign, the company is perfectly positioned to take advantage of the rapidly expanding collaborative health care market. I�m very enthused to be a part of the team that helps MEDecision realize this tremendous potential.� Later today, Dr. Schuyler will conduct a Market Insight presentation at the 5th Annual World Health Care Congress in Washington, D.C. The discussion, titled �The Use of Patient Clinical Information to Affect Care,� will take place at 3:55 p.m. EDT at the Marriott Wardman Park Hotel. Dr. Schuyler served in an executive capacity at Horizon BCBS since August 2004. He was responsible for concurrent medical management, medical policy, appeals and process redesign and development of integrated medical management. Prior to joining Horizon, Dr. Schuyler spent 17 years in managed care administration, including time with the former U.S. Healthcare and Aetna, last serving in the role of senior medical director. His earlier clinical and academic experience includes six years as associate director of a family practice residency training program affiliated with the University of Medicine and Dentistry of New Jersey, and four years in the private practice of family medicine. Dr. Schuyler completed his undergraduate studies at Williams College. He earned his medical degree from Cornell University Medical College and completed a combined Family Medicine and Psychiatry residency/fellowship at Columbia College of Physicians and Surgeons. For more information about MEDecision, please visit www.MEDecision.com. About MEDecision MEDecision offers collaborative health care management solutions that provide a simplified and smart way to manage the health of members and member populations which can improve the quality and affordability of care. Based on state-of-the-art technology, MEDecision�s solutions include Alineo�, a collaborative health care management platform for managing case, disease and utilization management and Nexalign�, a collaborative health care information exchange service. MEDecision believes that, in the aggregate, its health care payer customers insure or manage care for approximately one in every six people in the U.S. with health insurance. For more information, please visit www.MEDecision.com. MEDecision is a trademark of MEDecision, Inc. The MEDecision logo and product names are also trademarks or registered trademarks of MEDecision, Inc. Other product and brand names are trademarks of their respective owners. MEDE-G
Grafico Azioni Medecision (MM) (NASDAQ:MEDE)
Storico
Da Mag 2024 a Giu 2024 Clicca qui per i Grafici di Medecision (MM)
Grafico Azioni Medecision (MM) (NASDAQ:MEDE)
Storico
Da Giu 2023 a Giu 2024 Clicca qui per i Grafici di Medecision (MM)